Literature DB >> 6641713

Secretion of the hepatitis B virus surface antigen from mouse cells using an extra-chromosomal eucaryotic vector.

A Stenlund, D Lamy, J Moreno-Lopez, H Ahola, U Pettersson, P Tiollais.   

Abstract

Recombinant DNA molecules which contained a subgenomic fragment of the hepatitis B virus (HBV) genome, the pML2 vector and the bovine papillomavirus type 1 (BPV) genome were constructed. The HBV fragment includes the entire transcription unit for the hepatitis B surface antigen (HBsAg). After propagation in Escherichia coli, the recombinant plasmids were cleaved with endonucleases SalI and PvuI to eliminate most of the bacterial sequences before transfection of mouse C127 cells. Foci were observed 10--14 days after transfection. Cells from selected foci were cloned and the supernatants were assayed for the presence of HBsAg. Most of the clones tested were found to secrete HBsAg particles into the growth medium. These particles appear to be similar to the 22 nm particles present in the serum of HBV chronic carriers. SDS-polyacrylamide gel electrophoresis revealed that the particles contain two polypeptides, probably representing the glycosylated and unglycosylated forms of the HBsAg major polypeptide. An analysis of DNA from the transformed clones revealed that they contain multiple extra-chromosomal copies of the recombinant, which, however, had suffered rearrangement.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6641713      PMCID: PMC555167          DOI: 10.1002/j.1460-2075.1983.tb01482.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  21 in total

1.  AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS.

Authors:  I MACPHERSON; L MONTAGNIER
Journal:  Virology       Date:  1964-06       Impact factor: 3.616

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Effective subunit vaccines against an enveloped animal virus.

Authors:  B Morein; A Helenius; K Simons; R Pettersson; L Kääriäinen; V Schirrmacher
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

4.  A procedure for the isolation of mammalian messenger ribonucleic acid.

Authors:  G Brawerman; J Mendecki; S Y Lee
Journal:  Biochemistry       Date:  1972-02-15       Impact factor: 3.162

5.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA.

Authors:  D R Lowy; I Dvoretzky; R Shober; M F Law; L Engel; P M Howley
Journal:  Nature       Date:  1980-09-04       Impact factor: 49.962

7.  Synthesis and genomic site for an adenovirus type 2 early glycoprotein.

Authors:  H Persson; M Jansson; L Philipson
Journal:  J Mol Biol       Date:  1980-02-05       Impact factor: 5.469

8.  The integrated genome of murine leukemia virus.

Authors:  D Steffen; R A Weinberg
Journal:  Cell       Date:  1978-11       Impact factor: 41.582

9.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

10.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

View more
  11 in total

1.  Optimizing gene expression in BPV-transformed cells: effects of cell type on enhancer/promoter interaction.

Authors:  D R Hurwitz; R Hodges; W Drohan; N Sarver
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

Review 2.  The bovine papillomavirus genome and its uses as a eukaryotic vector.

Authors:  P E Stephens; C C Hentschel
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

3.  Hepatocyte-like cells transdifferentiated from a pancreatic origin can support replication of hepatitis B virus.

Authors:  Robert Yung-Liang Wang; Chia-Ning Shen; Min-Hui Lin; David Tosh; Chiaho Shih
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  The gene S promoter of hepatitis B virus confers constitutive gene expression.

Authors:  Y Malpièce; M L Michel; G Carloni; M Revel; P Tiollais; J Weissenbach
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

5.  Novel RNA family structure of hepatitis B virus expressed in human cells, using a helper-free adenovirus vector.

Authors:  I Saito; Y Oya; H Shimojo
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

6.  Expression of hepatitis B antigens with a simian virus 40 vector.

Authors:  H Will; R Cattaneo; E Pfaff; C Kuhn; M Roggendorf; H Schaller
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

7.  Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences.

Authors:  E Mandart; A Kay; F Galibert
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Foamy virus envelope glycoprotein is sufficient for particle budding and release.

Authors:  Kit L Shaw; Dirk Lindemann; Mark J Mulligan; Paul A Goepfert
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Expression of human epidermal growth factor precursor cDNA in transfected mouse NIH 3T3 cells.

Authors:  B Mroczkowski; M Reich; J Whittaker; G I Bell; S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

10.  Lines of BPV-transformed murine cells that constitutively express influenza virus hemagglutinin.

Authors:  J Sambrook; L Rodgers; J White; M J Gething
Journal:  EMBO J       Date:  1985-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.